These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 27318835)

  • 1. Efficacy and tolerability of Z-drug adjunction to antidepressant treatment for major depressive disorder: a systematic review and meta-analysis of randomized controlled trials.
    Kishi T; Matsunaga S; Iwata N
    Eur Arch Psychiatry Clin Neurosci; 2017 Mar; 267(2):149-161. PubMed ID: 27318835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brexpiprazole as Adjunctive Treatment for Major Depressive Disorder Following Treatment Failure With at Least One Antidepressant in the Current Episode: a Systematic Review and Meta-Analysis.
    Kishi T; Sakuma K; Nomura I; Matsuda Y; Mishima K; Iwata N
    Int J Neuropsychopharmacol; 2019 Nov; 22(11):698-709. PubMed ID: 31350882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levomilnacipran for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant--what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
    Citrome L
    Int J Clin Pract; 2013 Nov; 67(11):1089-104. PubMed ID: 24016209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressants available in Japan for older people with major depressive disorder: A systematic review and meta-analysis.
    Kishi T; Sakuma K; Hatano M; Okumura T; Kato M; Baba H; Iwata N
    Neuropsychopharmacol Rep; 2024 Mar; 44(1):267-271. PubMed ID: 38318955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy, tolerability, and acceptability of bupropion for major depressive disorder: a meta-analysis of randomized-controlled trials comparison with venlafaxine.
    Maneeton N; Maneeton B; Eurviriyanukul K; Srisurapanont M
    Drug Des Devel Ther; 2013; 7():1053-62. PubMed ID: 24101861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vilazodone for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
    Citrome L
    Int J Clin Pract; 2012 Apr; 66(4):356-68. PubMed ID: 22284853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Meta-Analysis of Memantine for Depression.
    Kishi T; Matsunaga S; Iwata N
    J Alzheimers Dis; 2017; 57(1):113-121. PubMed ID: 28222534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmentation of antidepressants with atypical antipsychotic medications for treatment-resistant major depressive disorder: a meta-analysis.
    Papakostas GI; Shelton RC; Smith J; Fava M
    J Clin Psychiatry; 2007 Jun; 68(6):826-31. PubMed ID: 17592905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Tolerability of Combination Treatments for Major Depression: Antidepressants plus Second-Generation Antipsychotics vs. Esketamine vs. Lithium.
    Vázquez GH; Bahji A; Undurraga J; Tondo L; Baldessarini RJ
    J Psychopharmacol; 2021 Aug; 35(8):890-900. PubMed ID: 34238049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brexpiprazole for schizophrenia and as adjunct for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antipsychotic - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
    Citrome L
    Int J Clin Pract; 2015 Sep; 69(9):978-97. PubMed ID: 26250067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety of Basimglurant as Adjunctive Therapy for Major Depression: A Randomized Clinical Trial.
    Quiroz JA; Tamburri P; Deptula D; Banken L; Beyer U; Rabbia M; Parkar N; Fontoura P; Santarelli L
    JAMA Psychiatry; 2016 Jul; 73(7):675-84. PubMed ID: 27304433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of milnacipran in the treatment of major depression in comparison with other antidepressants : a systematic review and meta-analysis.
    Nakagawa A; Watanabe N; Omori IM; Barbui C; Cipriani A; McGuire H; Churchill R; Furukawa TA;
    CNS Drugs; 2008; 22(7):587-602. PubMed ID: 18547127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are antipsychotics or antidepressants needed for psychotic depression? A systematic review and meta-analysis of trials comparing antidepressant or antipsychotic monotherapy with combination treatment.
    Farahani A; Correll CU
    J Clin Psychiatry; 2012 Apr; 73(4):486-96. PubMed ID: 22579147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-acetylcysteine as an adjunctive treatment for bipolar depression and major depressive disorder: a systematic review and meta-analysis of double-blind, randomized placebo-controlled trials.
    Kishi T; Miyake N; Okuya M; Sakuma K; Iwata N
    Psychopharmacology (Berl); 2020 Nov; 237(11):3481-3487. PubMed ID: 32767039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Newer antidepressant for Japanese adults with major depressive disorder: A systematic review and meta-analysis.
    Kishi T; Sakuma K; Hatano M; Matsuda Y; Esumi S; Miyake N; Miura I; Hori H; Kato M; Iwata N
    Neuropsychopharmacol Rep; 2024 Mar; 44(1):216-220. PubMed ID: 37646475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical assessment of lurasidone benefit and risk in the treatment of bipolar I depression using number needed to treat, number needed to harm, and likelihood to be helped or harmed.
    Citrome L; Ketter TA; Cucchiaro J; Loebel A
    J Affect Disord; 2014 Feb; 155():20-7. PubMed ID: 24246116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
    Tourian KA; Padmanabhan SK; Groark J; Brisard C; Farrington D
    Clin Ther; 2009 Jun; 31 Pt 1():1405-23. PubMed ID: 19698901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis.
    Cipriani A; Furukawa TA; Salanti G; Chaimani A; Atkinson LZ; Ogawa Y; Leucht S; Ruhe HG; Turner EH; Higgins JPT; Egger M; Takeshima N; Hayasaka Y; Imai H; Shinohara K; Tajika A; Ioannidis JPA; Geddes JR
    Lancet; 2018 Apr; 391(10128):1357-1366. PubMed ID: 29477251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of Hypericum perforatum in major depressive disorder in comparison with selective serotonin reuptake inhibitors: a meta-analysis.
    Rahimi R; Nikfar S; Abdollahi M
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):118-27. PubMed ID: 19028540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individual Differences in Response to Antidepressants: A Meta-analysis of Placebo-Controlled Randomized Clinical Trials.
    Maslej MM; Furukawa TA; Cipriani A; Andrews PW; Sanches M; Tomlinson A; Volkmann C; McCutcheon RA; Howes O; Guo X; Mulsant BH
    JAMA Psychiatry; 2021 May; 78(5):490-497. PubMed ID: 33595620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.